Persistent Asset Partners LTD Amicus Therapeutics, Inc. Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 303 shares of FOLD stock, worth $2,748. This represents 0.06% of its overall portfolio holdings.
Number of Shares
303Holding current value
$2,748% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$265 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$258 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$221 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$220 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$210 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.54B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...